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    Editorial
Platelet rich plasma (PRP), also termed autologous 
platelet  gel,  plasma  rich  in  growth  factors  (PRGF), 
platelet  concentrate  (PC),  is  essentially  an  increased 
concentration of autologous platelets suspended in a 
small amount of plasma after centrifugation. Basically, 
patient’s blood is collected and centrifuged at varying 
speeds  until  it  separates  into  3  layers:  platelet  poor 
plasma (PPP), PRP, and red blood cells. Usually 2 spins 
are  used.  The  first  spin  (“Hard  spin”)  separates  the 
platelet poor plasma (PPP) from the red fraction and 
platelet rich plasma (PRP). The second spin (“Soft spin”) 
separates the red fraction from the PRP. The material 
with the highest specific gravity (PRP) will be deposited at 
the bottom of the tube. Immediately prior to application, 
a platelet activator/agonist (topical bovine thrombin and 
10% calcium chloride) is added to activate the clotting 
cascade, producing a platelet gel.  The whole process 
takes approximately 12 minutes and produces a platelet 
concentration of 3-5x that of native plasma.1,2 
Platelets  play  a  fundamental  role  in  hemostasis 
and  are  a  natural  source  of  growth  factors.  Growth 
factors,  stored  within  platelet  α-granules,  include 
platelet  derived  growth  factor  (PDGF),  insulin  like 
growth factor (IGF), vascular endothelial growth factor 
(VEGF),  platelet  derived  angiogenic  factor  (PDAF), 
and  transforming  growth  factor  beta  (TGF-β).  The 
release  of  these  growth  factors  is  triggered  by  the 
activation of platelets that can be initiated by a variety 
of  substances  or  stimuli  such  as  thrombin,  calcium 
chloride, or collagen. Growth factors are involved in key 
stages  of  wound  healing  and  regenerative  processes 
including chemotaxis, proliferation, differentiation, and 
angiogenesis.3  According  to  the  definition  of  PRP,  it 
may be assumed that these growth factors are present 
at  increased  concentrations  in  PRP.  In  addition  to 
growth factors (GFs), platelets release numerous other 
substances  (e.g.,  fibronectin,  vitronectin,  sphingosine 
1-phosphate, etc…) that are important in wound healing. 
An advantage of PRP over the use of single recombinant 
human growth factor delivery is the release of multiple 
growth factors and differentiation factors upon platelet 
activation.4  Recently,  the  morphologic  and  molecular 
configuration of PRP was reported, it showed PRP is a 
fibrin framework over platelets that has the potential to 
support regenerative matrix.5,6 
The  rationale  for  using  PRP  in  soft  and  hard 
augmentation are to  accelerate vascularization of the 
graft, improve soft tissue healing, reduce post operative 
morbidity, and enhance bone regeneration.7 Advantages 
of  using  an  autologous  PRP  include  no  risk  of  cross 
reactivity, immune reaction or disease transmission.8 In 
addition, the use of PRP improves handling of particulate 
graft materials and easier packing into a grafting site, 
thus facilitating space maintenance and potential bone 
regeneration.9,10 
Since PRP contains several GFs (e.g., PDGF, VEGF, 
etc…) that are capable to stimulate angiogenesis and 
increase  fibroblast  cell  differentiation,  using  PRP 
to  promote  soft  tissue  healing  has  been  proposed.2 
Research  showed  that  PRP  and  analogous  products 
improve graft adhesion and minimizes micro-movement, 
providing the most advantageous environment for graft 
acceptance.11,12  It  has  been  also  proposed  that  PRP 
accelerates wound maturity and epithelialization, hence 
decreased scar formation. PDGF and epidermal growth 
factor  (EGF)  are  the  main  growth  factors  involved 
in  fibroblast  migration,  proliferation,  and  collagen 
synthesis.  Increased concentrations of these growth 
factors are likely the reason for the accelerated soft 
tissue wound healing, which is suggested to be at least 
2-3 times faster than that of normal.13 
For the hard tissue, growth factors released from PRP 
are likely to effect local vital cells such as osteoblasts. 
The addition of PRP to stromal cells has demonstrated 
angiogenic  and  osteogenic  properties  in  animal 
models.14 The use of PRP to enhance bone regeneration 
has  been  documented  in  periodontal  defects,15-17 
extraction  sockets,18  during  implant  placement,19,20  
and  in  guided  bone  regeneration  procedures  around 
implants, including sinus augmentation.21 
One of the major drawbacks of bone augmentation 
is the extended healing time required. Hence, one of the 
major reasons proposed for the use of PRP is a reduced 
healing time. A shortened graft healing time (50%) has 
been demonstrated in sinus augmentation.22 Accelerated 
bone  regeneration  has  also  been  demonstrated  in 
periodontal defects distal to second molars when PRP 
is  added  at  the  time  of  extraction  of  impacted  third 
molars.18 Unfortunately these results cannot be used to 
expound the beneficial effects of PRP, as biopsies were 
not taken from any of the control sites. 
In animal studies, when cancellous bone from the 
iliac crest was used as graft material for sinus lifts with 
or without PRP, biopsies showed both PRP and control 
groups  achieved  similar  results  with  no  statistically 
significant difference between the two.9,23 It is also true 
when DFDBA was used as a graft material, PRP did not 
enhance its ability to form bone.24 Similar findings were 
also reported when PRP was added to the xenograft 
(e.g.,  Bovine  HA).25  These  results  are  consistent  with 
those above that failed to demonstrate enhanced bone 
regeneration  when  PRP  is  combined  with  non-living 
graft materials.
In humans, early controlled studies demonstrated 
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enhanced  healing  and  bone  regeneration  with  PRP 
application.1,7 A short-term increase (e.g., improved at 
2 weeks but not at 12 weeks) of bone regeneration in 
sinus augmentation was observed when compared the 
β-TCP with or without PRP.26 Similar results have been 
demonstrated in minipigs,25 and adult domestic pigs.27 
When FDBA was used with PRP for subantral sinus 
augmentation, results showed the application of PRP 
will only result in accelerated new bone formation if 
target  cells  such  as  osteoblasts  and  osteocytes  are 
present.28 Also, study has reported that, when combined 
with anorganic bovine bone grafts, the addition of PRP 
had no effect on defect mineralization at any time point.26 
This  may  be  one  of  the  reasons  that  several  studies 
utilizing non vital grafting material have failed to show 
any beneficial effect.25,29,30 
Numerous reports have been published regarding 
the favorable effects of PRP on wound healing after bone 
augmentation. However, many are case reports lacking 
controls.31-34 Hence, a standardized research protocol 
should be used for future studies.  These include control 
of  the  quantification  of  platelet  yield  in  both  whole 
blood and PRP, use of commercial assays to quantify 
growth factor concentration, utilization of contralateral 
control groups, and proper histomorphometric analysis 
of specimens. The correlation between GF levels and 
histomorphometric result is another area that needs to 
be examined.  One of theories behind why PRP does not 
work may be the concentration of PRP from the machine 
is too low for the GFs to show the clinical effect. It would 
be interested to know if the concentration is increased 
to 10 times (versus 3-4 times) over the plasma, what 
kind of clinical results illustrated.
Safety of PRP remains to be an issue since increases 
GF in a local area may be a cancer promoting effects. 
Other concern is the use of bovine thrombin in activating 
the PRP release to cause immunogenic reaction.35 So 
far most of published data showed it is safe to use the 
product, however, future study in this area is certainly 
needed.
Currently there is a paucity of critical scientific data 
regarding the beneficial effects of platelet rich plasma in 
clinical procedures. There have been animal and human 
studies  both  purporting  and  refuting  its  adjunctive 
positive  effect.  In  theory,  PRP  has  many  beneficial 
effects  such  as  autologous  supply  of  growth  factors 
and improved wound healing. In addition it is relatively 
inexpensive  and  readily  available.  However,  from  the 
current available literature it is clear that there is great 
variability  in  study  design,  clinical  and  radiographic 
parameters that were measured, and clinical outcome. 
Many studies claiming a positive beneficial effect suffer 
from a poor study design. Many have no controls or a 
limited sample size. In general, conclusions advocating 
for an adjunctive effect are not supported by the study 
design. Therefore, the use of this material cannot be 
supported at present, and further controlled, prospective 
clinical trials are urgently needed.
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